ArticlePharmaceutics2026

Type 2 Diabetes Modulates Mesenchymal Stem Cell Response to Advanced Glycation End Products and N-Acetylcysteine Antioxidant Effect.

Rebecca Landon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.